Fatal Flaw: Imbalance in HEC Exposure

John highlights the key flaw: far more patients in the palonosetron arm received highly emetogenic chemotherapy.

Play episode from 11:34

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!